ArticleFrontiers in medicine2026
Risk factors for HR-HPV persistence and residual or recurrent high-grade squamous intraepithelial neoplasia after LEEP.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To investigate factors associated with persistent high-risk human papillomavirus (HR-HPV) infection and residual or recurrent disease in patients with high-grade squamous intraepithelial lesions (HSIL) following loop electrosurgical excision procedure (LEEP). Methods: A total of 903 patients with pathologically confirmed HSIL who underwent LEEP between January 2021 and May 2024 were retrospectively enrolled. HR-HPV genotyping and cervical cytology were performed before and after surgery, and residual or recurrent HSIL was assessed by colposcopy during follow-up. Generalized estimating equation (GEE) logistic regression accounted for within-patient clustering of genotype-specific HPV observations. Multivariable logistic regression identified factors associated with HR-HPV persistence, and Firth's penalized logistic regression evaluated factors associated with residual or recurrent HSIL. Results: Persistent HR-HPV infection rates were 23.3%, 19.0%, and 17.5% at 6, 12, and 18 months after LEEP, respectively. GEE analysis showed significant differences in type-specific persistence among the Conclusions:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.